Long-term prognosis of complete percutaneous coronary revascularisation in patients with diabetes with multivessel disease
- PMID: 25882502
- DOI: 10.1136/heartjnl-2014-307143
Long-term prognosis of complete percutaneous coronary revascularisation in patients with diabetes with multivessel disease
Abstract
Objective: There is a paucity of data on the impact of complete revascularisation (CR) following percutaneous coronary intervention (PCI) among patients with diabetes with multivessel coronary disease. In this study, we assess the impact of CR, using a relatively simple anatomical definition, on long-term outcomes (median follow-up 7.9 years) in patients with diabetes, and compare with patients without diabetes.
Methods: 5350 patients with multivessel disease (coronary stenoses ≥70% in ≥2 major epicardial arteries) who underwent PCI between January 1997 and June 2011 were included. Patients were divided into 4 groups according to diabetes and CR status (absence of residual coronary stenosis in major, predominantly proximal, epicardial segments according to Coronary Artery Surgery Study (CASS) classification).
Results: Patients with diabetes and patients with incomplete revascularisation (IR) had more adverse clinical and angiographic characteristics. IR was frequent in patients with diabetes, and was marginally more common than in patients without diabetes (47% vs 44%, p<0.001). Patients with diabetes and patients without diabetes had higher mortality rates after IR than after CR (HR 1.56 (95% CI (1.39 to 1.85), p<0.001 for patients with diabetes and 1.70 (95% CI (1.50 to 1.92), p<0.001) in patients without diabetes). However, the absolute risk was higher for patients with diabetes (5-year mortality: IR 35.8%, CR 21.2%) than in patients without diabetes (5-year mortality: IR 22.2%, CR 14.1%). In a multivariable model, IR and diabetes mellitus were independent predictors of total mortality. This effect was present in the bare metal stent and drug-eluting stent eras and in patients with stable disease and acute coronary syndromes.
Conclusions: CR is associated with lower long-term mortality in patients with diabetes and patients without diabetes. However the difference was significantly greater in patients with diabetes compared with patients without diabetes.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Comment in
-
Complete revascularisation in patients with diabetes.Heart. 2015 Aug;101(15):1176-7. doi: 10.1136/heartjnl-2015-307843. Epub 2015 May 13. Heart. 2015. PMID: 25972270 No abstract available.
Similar articles
-
Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.Catheter Cardiovasc Interv. 2013 Apr;81(5):759-65. doi: 10.1002/ccd.24438. Epub 2012 Apr 23. Catheter Cardiovasc Interv. 2013. PMID: 22488756
-
Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E155-62. doi: 10.1002/ccd.24732. Epub 2012 Dec 3. Catheter Cardiovasc Interv. 2013. PMID: 23109067
-
Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.JACC Cardiovasc Interv. 2014 May;7(5):471-81. doi: 10.1016/j.jcin.2013.12.201. JACC Cardiovasc Interv. 2014. PMID: 24852802
-
Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):344-54. doi: 10.1016/j.numecd.2013.11.002. Epub 2013 Dec 4. Nutr Metab Cardiovasc Dis. 2014. PMID: 24373711 Review.
-
Optimal approaches to diabetic patients with multivessel disease.Trends Cardiovasc Med. 2015 Oct;25(7):625-31. doi: 10.1016/j.tcm.2015.02.004. Epub 2015 Feb 19. Trends Cardiovasc Med. 2015. PMID: 26398271 Review.
Cited by
-
The effects of additional ezetimibe treatment to baseline rosuvastatin on circulating PCSK9 among patients with stable angina.J Thorac Dis. 2017 May;9(5):1226-1233. doi: 10.21037/jtd.2017.03.186. J Thorac Dis. 2017. PMID: 28616272 Free PMC article.
-
Overexpression of scavenger receptor and infiltration of macrophage in epicardial adipose tissue of patients with ischemic heart disease and diabetes.J Transl Med. 2019 Mar 20;17(1):95. doi: 10.1186/s12967-019-1842-2. J Transl Med. 2019. PMID: 30894181 Free PMC article.
-
Application of a Simple Microfluidic Chip Analysis Technology to Evaluate the Inhibitory Role of Protocatechuic Acid on Shear-Induced Platelet Aggregation.Evid Based Complement Alternat Med. 2021 May 18;2021:5574413. doi: 10.1155/2021/5574413. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34113388 Free PMC article.
-
Ejection Fraction Improvement Following Contemporary High-Risk Percutaneous Coronary Intervention: RESTORE EF Study Results.J Soc Cardiovasc Angiogr Interv. 2022 Aug 13;1(5):100350. doi: 10.1016/j.jscai.2022.100350. eCollection 2022 Sep-Oct. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39131473 Free PMC article.
-
Analysis of Fatigue Strength and Reliability of Lower Limb Arterial Stent at Different Vascular Stenosis Rates and Stent-to-Artery Ratios.Ann Biomed Eng. 2023 Jun;51(6):1136-1146. doi: 10.1007/s10439-023-03165-6. Epub 2023 Mar 20. Ann Biomed Eng. 2023. PMID: 36939956 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous